Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

By M. Muscaritoli, S. Anker, J. Argilés, Zaira Aversa, J. Bauer, G. Biolo, Y. Boirie, I. Bosaeus, T. Cederholm, P. Costelli and 7 more. Clinical Nutrition, 2010

1,618 citations recorded by the source corpus.

Subfields: Nutrition and Dietetics, Physiology

View Paper: https://www.semanticscholar.org/paper/51696504828c3aae0292957cda23f5052785d8ba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nutrition and Dietetics

In Physiology

Citations in the corpus

Sarcopenia: European consensus on definition and diagnosis (2010, background): “Very recently, a consensus paper expanding this definition of cachexia and identifying relevant issues on how to differentiate cachexia and sarcopenia was published by ESPEN, one of the EWGSOP-endorsing societies [25].”
Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta‐analysis (2019, result): “This highlights the importance of muscle strength or physical performance in the sarcopenia definition, in line with current definitions.(58,59,61,62,68,93) However, literatures also showed the value of including muscle mass in sarcopenia definitions.”
Clinical definition of sarcopenia. (2014, methodology): “The consensus definitions were as follows: • The presence of low skeletal muscle mass and either low muscle strength (e.g., handgrip) or low muscle performance (e.g., walking speed or muscle power); when all three conditions are present, severe sarcopenia may be diagnosed (EWGSOP); • The presence of”
Sarcopenia With Limited Mobility: An International Consensus (2011, background): “These factors/impediments have led to groups, originally from the European Union, and then from the European Union and the United States with industry support, to question the clinical feasibility of the original definition, and efforts to redefine sarcopenia have been advanced.(4,21,22) In an attem”
Hospital Malnutrition: Prevalence, Identification and Impact on Patients and the Healthcare System (2011, background): “Recently, the definition of malnutrition has been clarified by the European Society of Parenteral and Enteral Nutrition (ESPEN) to highlight the differences between cachexia, sarcopenia (loss of muscle mass and function) and malnutrition [18].”
ESPEN guidelines on definitions and terminology of clinical nutrition. (2017, methodology): “Patients with pre-cachexia are at risk of malnutrition due to the inflammatory response elicited by the underlying chronic disease [16,17] (see Section 3.”
ESPEN guidelines on nutrition in cancer patients. (2017, background): “Therefore, nutritional therapy should preferably be initiated when patients are not yet severely malnourished and when the goals of care include maintaining or improving nutritional status [21,23].”
ESPEN expert group recommendations for action against cancer-related malnutrition. (2017, background): “Sarcopenia is low lean body mass (mostly muscle); fatigue is common, strength may be lessened, and physical function limited [11,13].”
Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. (2015, background): “The malnutrition-related concepts cachexia [10,11], sarcopenia [11,12] and frailty [13] are today well-established.”